Can Employers Control Big Pharma Greed?
The pharmaceutical industry has become abundant with misuse and greed. Profit, shareholder returns and risk minimization are the primary goals for most stakeholders. Half of specialty drug spending is for cancer, rheumatoid arthritis, and multiple sclerosis. Saved lives and cured diseases are products of these primary objectives, but as a multi-trillion dollar money trail evolves, capitalism prevails. Predatory pricing is a major business strategy for many.
Click here to access the entire white paper.
Related News & Updates
Currently there are no PCSK9 inhibitors on the U.S. market but two approvals are anticipated this summer: Alirocumab (PRALUENT), manufactured by Sanofi/Regeneron is expected to receive approval by July 24,…
Better Benefits, No Headaches
3 min read
The last time you watched TV, how many times did you see a commercial from a pharmaceutical company? Perhaps you’ve seen an advertisement for Humira, Harvoni, Tecfidera or one of…
Better Benefits, Lower Costs
3 min read
Recently, I had the opportunity to hear some of the most interesting and credible views on where our healthcare system may be heading. For any of you that may be…
For years, the cost trend of prescription drugs has been relatively low compared to the medical cost trend. However, that paradigm is beginning to tip in the other direction, driven by…